Cargando…
Enrollment of Participants From Marginalized Racial and Ethnic Groups: A Comparative Assessment of the STEADY-PD III and SURE-PD3 Trials
BACKGROUND AND OBJECTIVES: Representation of persons from marginalized racial and ethnic groups in Parkinson disease (PD) trials has been low, limiting the generalizability of therapeutic options for individuals with PD. Two large phase 3 randomized clinical trials sponsored by the National Institut...
Autores principales: | Di Luca, Daniel G., Macklin, Eric A., Hodgeman, Karen, Lopez, Gisel, Pothier, Lindsay, Callahan, Katherine F., Lowell, Jill, Chan, James, Videnovic, Aleksandar, Lungu, Codrin, Lang, Anthony E., Litvan, Irene, Schwarzschild, Michael A., Simuni, Tatyana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973288/ https://www.ncbi.nlm.nih.gov/pubmed/36865634 http://dx.doi.org/10.1212/CPJ.0000000000200113 |
Ejemplares similares
-
A novel design of a Phase III trial of isradipine in early Parkinson disease (STEADY‐PD III)
por: Biglan, Kevin M., et al.
Publicado: (2017) -
Design of a virtual longitudinal observational study in Parkinson’s disease (AT‐HOME PD)
por: Schneider, Ruth B., et al.
Publicado: (2020) -
Increasing Efficiency of Recruitment in Early Parkinson’s Disease Trials: A Case Study Examination of the STEADY-PD III Trial
por: Berk, Sarah, et al.
Publicado: (2017) -
PD-1 modulates steady-state and infection-induced IL-10 production in vivo
por: McBerry, Cortez, et al.
Publicado: (2014) -
The Sure Foundation
Publicado: (1889)